Weekly paclitaxel in women age 65 and above with metastatic breast cancer

Edith A. Perez; Charles L. Vogel; David H. Irwin; Jeffrey J. Kirshner; Ravi Patel

doi:10.1023/A:1015230212550

Weekly paclitaxel in women age 65 and above with metastatic breast cancer

Edith A. Perez, Charles L. Vogel, David H. Irwin, Jeffrey J. Kirshner, Ravi Patel

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

We evaluated therapy with weekly paclitaxel 80 mg/m² in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with similar tolerability profiles in younger and older patients. Response rates and overall survival times were comparable in the two age groups (<65 and ≥65). Weekly paclitaxel therapy is a reasonable option for older patients with metastatic breast cancer.

Original language	English (US)
Pages (from-to)	85-88
Number of pages	4
Journal	Breast Cancer Research and Treatment
Volume	73
Issue number	1
DOIs	https://doi.org/10.1023/A:1015230212550
State	Published - 2002

Keywords

Breast cancer
Elderly
Metastatic
Paclitaxel
Weekly

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1023/A:1015230212550

Cite this

@article{ad93ac7244e84c9f8a81da87ed9e421b,

title = "Weekly paclitaxel in women age 65 and above with metastatic breast cancer",

abstract = "We evaluated therapy with weekly paclitaxel 80 mg/m2 in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with similar tolerability profiles in younger and older patients. Response rates and overall survival times were comparable in the two age groups (<65 and ≥65). Weekly paclitaxel therapy is a reasonable option for older patients with metastatic breast cancer.",

keywords = "Breast cancer, Elderly, Metastatic, Paclitaxel, Weekly",

author = "Perez, {Edith A.} and Vogel, {Charles L.} and Irwin, {David H.} and Kirshner, {Jeffrey J.} and Ravi Patel",

note = "Funding Information: ∗Supported by grants from Bristol-Myers Squibb Oncology, Princeton, NJ and the Breast Cancer Research Foundation, New York, NY.",

year = "2002",

doi = "10.1023/A:1015230212550",

language = "English (US)",

volume = "73",

pages = "85--88",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - Weekly paclitaxel in women age 65 and above with metastatic breast cancer

AU - Perez, Edith A.

AU - Vogel, Charles L.

AU - Irwin, David H.

AU - Kirshner, Jeffrey J.

AU - Patel, Ravi

N1 - Funding Information: ∗Supported by grants from Bristol-Myers Squibb Oncology, Princeton, NJ and the Breast Cancer Research Foundation, New York, NY.

PY - 2002

Y1 - 2002

N2 - We evaluated therapy with weekly paclitaxel 80 mg/m2 in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with similar tolerability profiles in younger and older patients. Response rates and overall survival times were comparable in the two age groups (<65 and ≥65). Weekly paclitaxel therapy is a reasonable option for older patients with metastatic breast cancer.

AB - We evaluated therapy with weekly paclitaxel 80 mg/m2 in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with similar tolerability profiles in younger and older patients. Response rates and overall survival times were comparable in the two age groups (<65 and ≥65). Weekly paclitaxel therapy is a reasonable option for older patients with metastatic breast cancer.

KW - Breast cancer

KW - Elderly

KW - Metastatic

KW - Paclitaxel

KW - Weekly

UR - http://www.scopus.com/inward/record.url?scp=0035985491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035985491&partnerID=8YFLogxK

U2 - 10.1023/A:1015230212550

DO - 10.1023/A:1015230212550

M3 - Article

C2 - 12083634

AN - SCOPUS:0035985491

SN - 0167-6806

VL - 73

SP - 85

EP - 88

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 1

ER -

Weekly paclitaxel in women age 65 and above with metastatic breast cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this